Lenalidomide Plus Rituximab for Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-Up and Subgroup Analyses From the Phase III AUGMENT Trial
Authors
C Thieblemont
Koji Izutsu (ORCID: https://orcid.org/0000-0001-9129-8057)
John P. Leonard (ORCID: https://orcid.org/0000-0002-5083-1115)
Grzegorz S. Nowakowski (ORCID: https://orcid.org/0000-0002-6955-9393)
Marek Trněný (ORCID: https://orcid.org/0000-0002-6952-6073)
Pier Luigi Zinzani (ORCID: https://orcid.org/0000-0002-2112-2651)
Jung Ryun Ahn
J GRIBBEN
Huilai Zhang
Nathan Fowler
on behalf of the AUGMENT Trial Investigators
Argyrios Gkasiamis
Institutions
The University of Texas MD Anderson Cancer Center (US)
Queen Mary University of London (GB)
Charles University (CZ)
Tianjin Medical University Cancer Institute and Hospital (CN)
Lenalidomide Plus Rituximab for Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-Up and Subgroup Analyses From the Phase III AUGMENT Trial
C Thieblemont, Koji Izutsu, John P. Leonard, Grzegorz S. Nowakowski et al.
Journal
Journal of Clinical Oncology
Topics
Lymphoma Diagnosis and Treatment
article
Lenalidomide Plus Rituximab for Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-Up and Subgroup Analyses From the Phase III AUGMENT Trial
C Thieblemont, Koji Izutsu, John P. Leonard, Grzegorz S. Nowakowski, Marek Trněný, Pier Luigi Zinzani, Jung Ryun Ahn, J GRIBBEN, Huilai Zhang, Nathan Fowler, on behalf of the AUGMENT Trial Investigators, Argyrios Gkasiamis
article en
Abstract
No abstract available for this paper.
Publication Tag
Journal of Clinical Oncology
Institutions
The University of Texas MD Anderson Cancer Center (US), Queen Mary University of London (GB), Charles University (CZ), Tianjin Medical University Cancer Institute and Hospital (CN), NYU Langone Health (US), Bristol-Myers Squibb (United States) (US), Istituto di Ematologia di Bologna (IT), Mayo Clinic in Arizona (US), Hôpital Saint-Louis (FR), Tokyo National Hospital (JP), Bristol-Myers Squibb (Switzerland) (CH), New York University (US), University of Bologna (IT)